How long does it take to take sparsentan/sparsentan to treat IgA nephropathy?

Sparsentan/Sparsentan is a new type of drug mainly used to treat IgA nephropathy (IgA Nephropathy). In clinical studies, sparsentane has shown good efficacy and can significantly reduce urinary protein excretion and improve renal function. However, how long you need to take it to treat IgA nephropathy may depend on multiple factors, including the patient's specific condition, treatment response, tolerance, and doctor's recommendations.

The mechanism of action of sparsentane is to selectively antagonize endogenous epinephrine and angiotensin receptors, thereby reducing the inflammation and fibrosis response of the kidney, thereby protecting renal function. Judging from the results of clinical trials, sparsentane has shown good efficacy in the treatment of IgA nephropathy. For example, in the PROTECT phase 3 clinical trial, patients treated with sparsentan had an average reduction in proteinuria of 49.8% after 36 weeks of treatment, a result that was significantly better than that of patients treated with irbesartan. This suggests that sparsentane can effectively reduce proteinuria levels in patients with IgA nephropathy, thereby potentially delaying the progression of the disease.

However, this does not mean that all patients with IgA nephropathy need to take sparsentane for 36 weeks or longer. In fact, treatment cycles may last from months to years, depending on the patient's condition. For patients with milder disease and a good response to treatment, it may be possible to achieve treatment goals and discontinue medication in a shorter period of time; while for patients with more severe disease and a slower response to treatment, longer treatment may be required.

In addition, patients need to be closely monitored for changes in condition and drug side effects while taking sparsentane. If adverse reactions occur or the treatment is not effective, the doctor may adjust the treatment plan or discontinue the medication. Therefore, patients should strictly follow the doctor's instructions for treatment and maintain close communication with the doctor during the treatment process.